Special Populations in MDS: Practical Considerations in the Management of Disease-related Anemia

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: May 08, 2019
Expiration Date: May 08, 2020

Expected time to complete this activity as designed: 15 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

Anemia is the most common cytopenia at diagnosis, which may be present in upwards of 80% of patients. In this activity, Dr. Alan List will review the recent studies that are available for patients who are ESA-refractory. He will also review the results of the MEDALIST trial and where luspatercept will fit into clinical practice for patients with lower-risk MDS.

Target Audience

This activity is designed for multidisciplinary healthcare providers in the community setting, including hematologists, oncologists, pharmacists and other allied healthcare professionals who provide care to patients with myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify the clinical impact of serious disease-related conditions such as persistent anemia on morbidity and quality of life in elderly patients with lower-risk MDS
  • Assess the current unmet need in treatment availability for patients with MDS who are transfusion dependent
  • Describe practical strategies for managing anemia and other disease-related conditions in elderly patients with lower-risk MDS


Special Populations in MDS: Practical Considerations in the Management of Disease-related Anemia – Alan F. List, MD

Instructions for Participation and Credit

This activity is eligible for credit through May 08, 2020. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Alan F. List, MD
President & CEO
H. Lee Moffitt Cancer Center
Professor, Department of Oncologic Sciences
College of Medicine, University of South Florida
Tampa, Florida

Dr. Alan List received his medical degree from the University of Pennsylvania College of Medicine. He completed his internship and residency in internal medicine at Good Samaritan Medical Center, Phoenix, and his oncology and hematology fellowships at Vanderbilt University Medical Center, Nashville. Dr. List is President & CEO at H. Lee Moffitt Cancer Center, and a Professor in the Department of Oncologic Sciences, College of Medicine, at the University of South Florida in Tampa.

Dr. List is a National Board of Medical Examiners and American Board of Internal Medicine (ABIM) diplomat with an oncology and hematology subspecialty. He holds membership in the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, Southwestern Oncology Group, and the Florida Society of Clinical Oncology (FLASCO). In addition, Dr. List is an ad hoc reviewer for Blood, New England Journal of Medicine, Cancer, Leukemia Research, Oncogene, Journal of Clinical Oncology, Cancer Research, Cell, and Leukemia, among others. He holds more than 20 patents, and has written and presented hundreds of journal articles and abstracts. Dr. List is internationally recognized for his many contributions in the development of novel and effective treatment strategies for myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).


Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.25 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-19-013-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.


As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Alan List has received honoraria as a consultant as well as grant support related to research activities from Celgene Corporation.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Kristin Burke and Andrea Mathis, Project Managers, Andrew Bowser, Medical Writer, and Joan Meyer, RN, MHA, Executive Director, have no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at lisa@medicaled.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Astex, Celgene Corporation, and Takeda Oncology.

©2019 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.